This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Adenocarcinoma of the lung

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Adenocarcinomata tend to occur more peripherally than squamous cell carcinomata (SCC). Adenocarcinoma accounts for approximately 20% of lung tumours - though this may be increasing - and with equal incidence in both sexes. The association with smoking is less strong than for SCC.

Adenocarinoma is the most common lung tumour in non-smokers and the lung tumour most frequently associated with asbestos.

Atelectasis and emphysema are less common in adenocarcinoma as the major bronchi are usually not impaired.

Histologically, these tumours contain epithelial mucin which stains positive with mucicarmine. Four types are recognised by the WHO classification, but in practice, two types are distinguished:

  • bronchial-derived - incorporating acinar, papillary, and solid - with mucin production; may occur in association with old trauma, tuberculosis and infarctions, and has been described as a 'scar cancer'

  • bronchio-alveolar - which grow along pre-existing alveolar septae

There is little difference between these two groups in terms of treatment response or survival, which on account of the relatively slow growth of these tumours, tends to be more favourable than for other lung tumours.

Lung adenocarcinomas may present a diagnostic difficulty in that an apparent primary tumour may prove to be a metastasis from a tumour of the gastrointestinal tract, ovary, pancreas, kidney, thyroid, or breast.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.